Company intelligence / Profile preview

FeelTect

Spiddal, County Galway, Ireland

Ownership: Private
Development stage: Other

Overview

Initial clinical studies show that Tight Alright enables more consistent application of targeted compression therapy for leg ulcers, with some patients achieving up to 38% wound reduction in just three weeks. The technology has completed FDA Class I and CE Mark registration, and international patient studies indicate improved application compared to traditional methods. Efficacy and health economic validations are ongoing.

Therapeutic areas: DermatologyCardiovascular
Modalities: DeviceDigital health
Industry: Physiological Monitoring

Partnerships

Western Development CommissionEnterprise IrelandUniversity of Galway

Beyond the preview

Go deeper on FeelTect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FeelTect.

Explore the full profile